07/14/2025
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2025
3:22 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/27/2025
3:39 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2025
6:30 AM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2025
4:36 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/25/2025
3:36 PM | Giltner Richard (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2025
3:38 PM | Mesa Nilda (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
4:25 PM | Mesa Nilda (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2025
3:57 PM | Giltner Richard (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/16/2025
7:48 AM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2025
3:30 PM | EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for UTHR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for United Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
06/02/2025
3:39 PM | EDGEMOND JAMES (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/12/2025
3:30 PM | Thompson Tommy G (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2025
9:44 AM | United Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
05/02/2025
3:31 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2025
5:32 AM | United Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/30/2025
5:33 AM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2025
5:31 AM | United Therapeutics (Filer)
| Form DEF 14A | |
04/29/2025
5:33 AM | United Therapeutics (Filer)
| Form DEFA14A | |
04/29/2025
5:36 AM | United Therapeutics (Filer)
| Form ARS | |
04/28/2025
5:31 AM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2025
3:30 PM | DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2025
3:28 PM | DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/14/2025
3:02 PM | DWEK RAYMOND (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/07/2025
3:01 PM | DWEK RAYMOND (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/07/2025
8:05 AM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2025
3:31 PM | Thompson Tommy G (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/24/2025
3:47 PM | Thompson Tommy G (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2025
5:11 PM | PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
3:11 PM | PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2025
3:30 PM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
3:31 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:33 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:41 PM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
3:31 PM | KURZWEIL RAY (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
3:34 PM | Thompson Tommy G (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2025
5:33 AM | United Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/26/2025
5:35 AM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/25/2025
3:30 PM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
3:30 PM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Missed the Run So Far? This Is Your Second Chance (Ad) According to history, the final stretch of the crypto cycle is here — and this short window is where fortunes are made.
Inside The Crypto Code Workshop, two experts reveal how to get positioned early, lock in profits, and access their top altcoin picks before the crowd. All attendees receive $10 in free Bitcoin just for showing up. Join The Crypto Code Workshop + get $10 in Bitcoin for attending |
02/11/2025
3:32 PM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
9:25 AM | United Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
02/05/2025
6:10 AM | STATE STREET CORP (Filed by)
United Therapeutics (Subject)
| Form SCHEDULE 13G | |
01/22/2025
3:30 PM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
3:31 PM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
3:30 PM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
3:30 PM | PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
7:57 AM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
3:29 PM | PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/07/2025
3:30 PM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:31 PM | Mesa Nilda (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:32 PM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
3:08 PM | Mesa Nilda (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2024
3:30 PM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
3:31 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
4:51 PM | SULLIVAN LOUIS W (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/17/2024
3:31 PM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
3:38 PM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024
3:32 PM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
3:30 PM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
5:44 AM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
4:37 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
4:04 PM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/12/2024
10:32 AM | Olian Judy D. (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2024
3:17 PM | Mesa Nilda (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024
4:07 PM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/05/2024
3:30 PM | EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:33 PM | Giltner Richard (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024
3:45 PM | CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024
3:23 PM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/30/2024
5:32 AM | United Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/30/2024
5:34 AM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/29/2024
3:30 PM | EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2024
3:13 PM | EDGEMOND JAMES (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/22/2024
3:30 PM | EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
4:19 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
12:03 PM | STATE STREET CORP (Filed by)
United Therapeutics (Subject)
| Form SC 13G | |
10/15/2024
3:30 PM | EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
7:19 AM | EDGEMOND JAMES (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/08/2024
3:30 PM | EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2024
3:30 PM | EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/23/2024
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
3:30 PM | EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
3:30 PM | Olian Judy D. (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
3:20 PM | EDGEMOND JAMES (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024
3:30 PM | EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
3:30 PM | PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
3:34 PM | EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
3:35 PM | PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/03/2024
3:18 PM | EDGEMOND JAMES (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Trump’s national nightmare is here (Ad) Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II.
They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes. Watch the National Emergency broadcast here |
08/28/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
3:30 PM | EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
3:24 PM | EDGEMOND JAMES (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/22/2024
3:30 PM | CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:30 PM | EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
